Ropeginterferon alfa-2b versus standard therapy for polycythaemia vera (PROUD-PV and CONTINUATION-PV): a randomised, non-inferiority, phase 3 trial and its extension study - Gisslinger, H; Klade, C; Georgiev, P; PROUD-PV Study Group (Lancet Haematol, 2020)